DHRDanaher Corporation
Danaher is a global science and technology innovator committed to accelerating the power of science and technology to improve human health. 10-K, Item 1
- Employees
- 60,000
- Headquarters
- Washington, DC
- CEO
- Rainer Blair
- Next results
- around Jan 11, 2027
What DHR's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Facts only; most of these sales are routine, such as selling shares from vesting stock awards.
Trading plans adopted or ended
1 plan still running: Rainer M. Blair.
| Insider | What | Date | Shares | Runs to | Reported in |
|---|---|---|---|---|---|
| Rainer M. Blair then-President and Chief Executive Officer and director |
Adopted 10b5-1 plan | Aug 7, 2026 | up to 60,015 | Feb 6, 2027 | 10-Q Oct 21, 2026 |
| Rainer M. Blair President and Chief Executive Officer |
Adopted 10b5-1 plan | May 30, 2025 | up to 60,015 | May 29, 2026 | 10-Q Jul 22, 2025 |
The company's descriptionOn May 30, 2025, Rainer M. Blair, Danaher’s President and Chief Executive Officer, adopted a trading plan that is intended to satisfy the affirmative defense conditions of Securities Exchange Act Rule 10b5-1(c) for the sale through May 29, 2026 of up to 60,015 shares of Danaher common stock pursuant to the exercise of stock options otherwise scheduled to expire in February 2027. | |||||
| Rainer M. Blair | Adopted 10b5-1 plan | Nov 28, 2023 | up to 103,379 | 359 days | 10-K Feb 21, 2024 |
From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 25, 2023.
Form 144 notices of planned sales
| Filed | Seller | Shares | Value | Shares came from | 10b5-1 plan | Form 4 sales after |
|---|---|---|---|---|---|---|
| Nov 9, 2026 | McGrew Matthew Former Officer |
17,385 | $4,097,452 | Stock Option Exercise | none given | none found |
| Nov 9, 2026 | Blair Rainer Former Officer, BOD |
71,963 | $16,854,420 | Option Granted; Restricted Stock Vesting | adopted Aug 7, 2026 | none found |
| Nov 9, 2026 | Milosevich Gregory M Officer |
2,100 | $484,302 | Restricted Stock Vesting | none given | none found |
| Oct 28, 2026 | McGrew Matthew Officer |
29,754 | $7,014,244 | Restricted Stock Vesting; Stock Option Exercise | none given | 29,754 shares from Oct 28, 2026 |
| Aug 21, 2026 | Rainer M. Blair Officer |
58,255 | $12,749,107 | Acquired as compensation -- Restricted Stock Units | none given | 58,255 shares from Aug 21, 2026 |
| Jul 14, 2026 | SCHWIETERS JOHN T Former Director |
3,298 | $658,254 | Stock Option Exercise | none given | none found |
| May 1, 2026 | SPOON ALAN G Director |
1,358 | $237,207 | Options Granted - 07/15/2016 | none given | 1,358 shares from May 1, 2026 |
| Feb 19, 2026 | Milosevich Gregory M Officer |
1,320 | $274,575 | Option Granted - 02/24/2016 | none given | none found |
| Nov 25, 2025 | The Mitchell P. Rales Family Trust See Remarks |
40,625 | $9,221,063 | Distribution from closely-held corporation | none given | none found |
| Nov 25, 2025 | Glenstone Foundation See Remarks |
146,957 | $33,356,300 | Gift from Affiliate | none given | none found |
| Nov 18, 2025 | List Teri Director |
3,298 | $746,997 | Option Granted - 07/15/2016 | none given | none found |
| Nov 12, 2025 | Ellis Brian W Officer |
21,776 | $4,773,864 | Option Granted - 02/24/2016 | none given | none found |
| Nov 12, 2025 | McGrew Matthew Officer |
16,172 | $3,470,831 | Option Granted- 11/15/2015 | none given | none found |
| Nov 12, 2025 | Mitchell P. Rales Dir; Chmn. of Exec. Comm. |
437,000 | $91,743,780 | Distribution from closely-held corporation | none given | none found |
| Nov 10, 2025 | Couchara Georgeann Officer |
5,174 | $1,088,704 | Options Granted - 02/24/2018; Restricted Stock Vesting | none given | none found |
| Oct 31, 2025 | Mitchell P. Rales Dir; Chmn. of Exec. Comm. |
600,000 | $128,406,000 | Distribution from closely-held corporation | none given | none found |
From the Form 144 XML filed with the SEC, since Oct 31, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.
Work on DHR in a spreadsheet:
Excel workbook (a sheet per section, ten years by column, charts, links to the filings) ·
CSV.
For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/DHR/export.csv") into a cell.